Tumor-necrosis-factor-related apoptosis-inducing ligand and the regulation of hematopoiesis.
about
Clinical perspectives of TRAIL: insights into central nervous system disordersCirculating TRAIL shows a significant post-partum decline associated to stressful conditionsSelection and characterization of a novel agonistic human recombinant anti-TRAIL-R2 minibody with anti-leukemic activity.Molecular targets for selective killing of TRAIL-resistant leukemic cells.Sodium dichloroacetate exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3.Inhibition of TACE activity enhances the susceptibility of myeloma cells to TRAIL.Levels of circulating TNF-related apoptosis-inducing ligand in celiac diseaseIntranasal administration of recombinant TRAIL down-regulates CXCL-1/KC in an ovalbumin-induced airway inflammation murine modelThe p53 transcriptional pathway is preserved in ATMmutated and NOTCH1mutated chronic lymphocytic leukemias.The anti-leukemic activity of sodium dichloroacetate in p53mutated/null cells is mediated by a p53-independent ILF3/p21 pathwayType 1 interferons suppress accelerated osteoclastogenesis and prevent loss of bone mass during systemic inflammatory responses to Pneumocystis lung infection.Kinetic Profiles of Inflammatory Mediators in the Conjunctival Sac Fluid of Patients upon Photorefractive Keratectomy.Creating a tumor-resistant microenvironment: cell-mediated delivery of TNFα completely prevents breast cancer tumor formation in vivo.Stroma-dependent apoptosis in clonal hematopoietic precursors correlates with expression of PYCARD.Apoptosis by dietary agents for prevention and treatment of cancer.GM-CSF exhibits anti-inflammatory activity on endothelial cells derived from chronic venous disease patients.Modulation of circulating cytokine-chemokine profile in patients affected by chronic venous insufficiency undergoing surgical hemodynamic correction.Immunological derangement in hypocellular myelodysplastic syndromes.Surviving apoptosis: life-death signaling in single cells.MiR-942 decreased before 20 weeks gestation in women with preeclampsia and was associated with the pathophysiology of preeclampsia in vitro.Circulating levels of TNF-related apoptosis inducing-ligand are decreased in patients with large adult-type granulosa cell tumors-implications for therapeutic potential.AML1/ETO sensitizes via TRAIL acute myeloid leukemia cells to the pro-apoptotic effects of hypoxia.Regulatory functions of TRAIL in hematopoietic progenitors: human umbilical cord blood and murine bone marrow transplantation.Soluble TRAIL is elevated in recurrent miscarriage and inhibits the in vitro adhesion and migration of HTR8 trophoblastic cells.TNF-related apoptosis inducing ligand in ocular cancers and ocular diabetic complications.Trail down-regulates the release of osteoprotegerin (OPG) by primary stromal cells.Non-canonical role for the TRAIL receptor DR5/FADD/caspase pathway in the regulation of MyoD expression and skeletal myoblast differentiationLevels of TNF-related apoptosis-inducing ligand (TRAIL) show a long-term stability in the breast milk of mothers of preterm infants.Pegylated TRAIL retains anti-leukemic cytotoxicity and exhibits improved signal transduction activity with respect to TRAIL.Activation of PKC-ε counteracts maturation and apoptosis of HL-60 myeloid leukemic cells in response to TNF family members.The levels of circulating TRAIL at the onset of type 1 diabetes are markedly decreased in patients with ketoacidosis and with the highest insulin requirement.MCL1 down-regulation plays a critical role in mediating the higher anti-leukaemic activity of the multi-kinase inhibitor Sorafenib with respect to Dasatinib.TRAIL shows potential cardioprotective activityThe negative prognostic value of TRAIL overexpression in oral squamous cell carcinomas does not preclude the potential therapeutic use of recombinant TRAIL
P2860
Q26766570-457F287F-DC3F-44C9-8FBD-52CDDCD67BEBQ28478386-7CF84F45-1B78-475E-ADBF-8B6ECF658804Q33421148-E643046E-B161-4A58-A234-822B25B33EE5Q33891400-149C0AD0-B03F-483B-870F-883AA4B7EFDAQ34100963-CD7E82F1-4F55-4177-BCD3-B75173DF84ABQ34184457-DFEFCFC8-DEF9-4261-A7C7-1506BDCCAB1BQ34445054-D276ACAD-7928-49C8-9174-0FE72F8E4BFCQ34704284-E2E2509F-6A79-4CEF-93D6-BC985A4382FEQ35149661-C658A523-630A-4F48-BC1B-16C10C40045CQ35273665-B5BAF74D-3D3D-4BBF-99E4-8BB941A1BFF9Q36071793-CF139E0B-F532-4C66-85A6-5D28DAA5314CQ36197930-C3C2552C-29BA-4257-AE5A-9EDB93422278Q36654392-3EB2F1DC-E363-4EFF-8A7A-45C7EDE76065Q37066254-24F7F89C-847F-4C3A-9811-56C3DC569C95Q37240356-94FA6B6C-5D4A-425A-9DC7-5AB954F746FAQ37353637-3FE6A74F-2992-4565-930C-2A89031E68B7Q37699909-8450CA3C-5D7B-46DD-B276-9D1F20008420Q37724605-B661C665-A2B6-459B-B4DB-623F86CE05B4Q38446898-0A1BFAFA-AFB0-427B-B938-F7F509E8A63CQ38712440-662E45C6-9FEA-48AC-9DC6-E431F7836C55Q38737133-DB535C4F-B0F9-4355-8AD9-FC58DE2A514EQ39181108-61A913E2-6081-45F0-856F-87E0724083E9Q39256130-FD2803C7-8D8D-4C96-82F4-B392016C6C5FQ39292824-9E335227-FD66-4259-B6C6-6D4887DBAA6DQ41123139-5B61B5DE-2586-4A62-BF57-CE93569D3686Q42489788-FEC47478-F6BE-4B16-B64C-C94BA32E67BAQ42678177-8C5D3320-5B4B-42D4-B1E6-D8FEBCA05A93Q43414740-6BDA54A1-FF58-4522-928D-145DC236F15EQ44230417-A9836B25-5AB3-4A05-8C34-85A30740CE4CQ47131195-5E53DD77-A09E-4937-A308-BB6130034DCBQ47832405-2F3B37BA-6392-446B-AFFC-F031E3B8E05EQ54531407-90EDF129-2319-4205-BC41-80BB3089DAA2Q57182302-62940D78-53EA-422E-944C-4D38F63E9838Q57200151-EAF0787E-8CB5-4968-A186-F8F3DEC76B59
P2860
Tumor-necrosis-factor-related apoptosis-inducing ligand and the regulation of hematopoiesis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Tumor-necrosis-factor-related ...... e regulation of hematopoiesis.
@en
Tumor-necrosis-factor-related ...... e regulation of hematopoiesis.
@nl
type
label
Tumor-necrosis-factor-related ...... e regulation of hematopoiesis.
@en
Tumor-necrosis-factor-related ...... e regulation of hematopoiesis.
@nl
prefLabel
Tumor-necrosis-factor-related ...... e regulation of hematopoiesis.
@en
Tumor-necrosis-factor-related ...... e regulation of hematopoiesis.
@nl
P1476
Tumor-necrosis-factor-related ...... e regulation of hematopoiesis.
@en
P356
10.1097/MOH.0B013E3282F15FA6
P577
2008-01-01T00:00:00Z